Tamtam Try Tamtam free
Apoteket AB logo

Apoteket AB account plan

Leading pharmacy health services

At a glance

Apoteket is Sweden's state-owned pharmacy chain: SEK 27,062 million 2025 net sales, 398 pharmacies, e-commerce and dose services, 4,440 employees.

Apoteket AB (publ) is a pharmacy company wholly owned by the Swedish state and run on market terms, headquartered in Solna. It sells prescription and over-the-counter medicines and other pharmacy products through about 395 outpatient pharmacies, 526 pharmacy agents, apoteket.se and an app, and supplies medicines, dose packaging and pharmacy services to regions, municipalities and care providers. FY2025 net sales were SEK 27,062 million (+6.6%), operating profit SEK 564 million (margin 2.1%) and net profit SEK 665 million; it had 4,440 employees at 31 December 2025. Rasmus Nerman has been CEO since 2022 and Ingrid Bonde chairs the board.

Business units

Strategic priorities

Reaching the 3% operating margin target
The long-term operating margin target is 3.0%; the rolling 12-month margin to September 2026 was 2.3%, against 2.1% in 2025.
Omnichannel and e-commerce
E-commerce reached 25.6% of Swedish pharmacy market sales in 2025; Apoteket integrates pharmacies, web, app and digital services while continuing to open and upgrade pharmacies, with several openings planned for autumn 2026 and 2027.
Growing dose and care contracts
New contracts with Region Skåne (from September 2025), Region Halland and Kriminalvården (from November 2025), and an expanded role in the Armed Forces' emergency stockpiles.
A bigger clinical role for pharmacists
The inhaler-guidance service has been rolled out in all outpatient pharmacies; Apoteket tested remote pharmacists via an iPad in December 2024.
Data and AI
Apoteket launched a new analytics platform and decision support in 2025, has an internal AI council, and says AI is gradually becoming part of daily work.
Climate targets
Cut emissions from goods transport, energy, company cars and refrigerants by 70% by 2030 versus 2020, and have 90% of suppliers by purchase cost on the Science Based Targets initiative (61% in 2025).

Latest results

In Q3 2026 (July-September) net sales rose 9.5% to SEK 7,251 million and operating profit to SEK 235 million from SEK 158 million, a 3.2% margin (2.4%), helped by consumer sales, better pricing and improved profitability in dose and care. For January-September 2026 net sales were SEK 22,310 million (+13.1%), operating profit SEK 546 million (margin 2.4%) and net profit SEK 607 million. Costs rose mainly from tech investments and the start-up of the new care contract. The report gives no numeric guidance beyond the long-term targets.

Investments and deals

Store, contract and IT investment
Investments were SEK 183 million in 2025 (92 in 2024), mainly store fittings, adaptations for the Region Skåne contract and new IT solutions; SEK 106 million in January-September 2026.
Pharmacy network
Six pharmacies were opened and three closed in 2025, with more openings planned for autumn 2026 and 2027.
Preparedness stocks
Apoteket has raised stock levels on several medicines and taken expanded responsibility for parts of the Armed Forces' emergency stockpiles.

Challenges and risks

Price pressure from online players
Pure online competitors and the channel shift to e-commerce drive price pressure, while prescription reimbursement set by TLV is about break-even.
Pharmacist and IT skills shortage
The pharmacist shortage forced Apoteket to adjust opening hours at about 150 pharmacies in summer 2025.
Security and cyber threats
Apoteket had six robberies in 2025, four in vulnerable areas, requiring alarms, cameras and double staffing; cyber threats are becoming more sophisticated.
Dose and care profitability
The annual report calls profitability in this market still challenging, as several supply contracts lost value while regions take work in-house.
Drug shortages and pension commitment
Tariffs and disruptions sustain the risk of drug shortages, and the large pension commitment in Apotekets Pensionsstiftelse could require capital injections.

What leadership says

“Vi måste investera mer i säkerhet, bland annat i form av larm och kameror.”

Rasmus Nerman, CEO · Tidningen Näringslivet interview, 11 August 2026, on pharmacy robberies (we must invest more in security, including alarms and cameras)

“Apotekens tillgänglighet hotas av en växande brist på farmaceuter”

Rasmus Nerman, CEO · Svensk Farmaci feature on remote pharmacists, 28 October 2025 (pharmacy access is threatened by a growing pharmacist shortage)

“Jag vill dock vara tydlig med att jag inte ser att farmaceuter på distans ska ersätta lokala farmaceuter utan komplettera vid behov.”

Rasmus Nerman, CEO · Svensk Farmaci, 28 October 2025 (remote pharmacists should complement, not replace, local pharmacists)

Where a supplier can help

Remote pharmacist platforms
Tied to the pharmacist shortage and the clinical-role priority: a digital platform for remote consultations is what the CEO expects to be part of the solution.
Store security
Tied to the security challenge: alarms, cameras, guarding and cash handling services address the stated costs in vulnerable areas.
Data, AI and analytics
Tied to the data and AI priority and rising tech investment: analytics, decision support and AI tools for pharmacy and logistics workflows.
Logistics and compounding capacity
Tied to the growing dose and care contracts: hospital supply, dose packaging, cold chain and preparedness stock solutions support contracts such as Region Skåne.
Low-emission transport
Tied to the 70% emissions-cut target: fossil-free delivery and energy-efficiency suppliers fit a target missed so far (4.1 thousand tonnes CO2e in 2025 vs 3.4).

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Apoteket AB?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Apoteket AB

What does Apoteket do?

Apoteket runs pharmacies, pharmacy agents and e-commerce across Sweden, and supplies medicines, dose packaging and pharmacy services to regions, municipalities and care providers.

What was Apoteket's revenue in 2025?

Net sales were SEK 27,062 million in 2025, up 6.6%, with operating profit of SEK 564 million.

How many employees does Apoteket have?

Apoteket had 4,440 employees at 31 December 2025.

Who owns and leads Apoteket?

Apoteket is wholly owned by the Swedish state. Rasmus Nerman is CEO and Ingrid Bonde chairs the board.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)